Abhishek Kumar Thakur, Naveen Gupta, Dharmendra Singh Rajput, Neeraj Sharma
Abhishek Kumar Thakur, Naveen Gupta, Dharmendra Singh Rajput, Neeraj Sharma
Patel College of Pharmacy, Madhyanchal Professional University, Ratibad, Bhopal-462044, MP.
Volume - 13,
Issue - 3,
Year - 2021
This Present research with dispersible tablet can compromise the efficacy and safety of the treatment to children’s and geriatric patients with masking the bitter taste of drug and developing its dispersible tablet. The purpose of this research work was to develop Dispersible tablet of Ornidazole by masking the bitter taste. Tablet containing drug and excipients were prepared by direct compression method. Excipients in combinations were incorporated to achieve the aim. Effect of different combinations was studied to optimize the ideal formulation. Drug excipients interaction studies were carried out by FTIR spectral analysis. The tablets were evaluated for their hardness, wetting time, disintegrating time and dissolution parameters. It was concluded that the tablets having the combination of Dried Mucilage (obtained from dried seeds of ocimum bacilicum) and Sodium starch glycolate met all the evaluation parameters and thus selected as the optimized formulation. Optimized formulation was undergone for stability testing as a parameter to predict the shelf life as per ICH guidelines and proved for its adequate shelf life.
Cite this article:
Abhishek Kumar Thakur, Naveen Gupta, Dharmendra Singh Rajput, Neeraj Sharma. Development, Formulation and Evaluation of Sustain Release Dispersible Tablet of Ornidazole. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):174-8. doi: 10.52711/0975-4377.2021.00031
Abhishek Kumar Thakur, Naveen Gupta, Dharmendra Singh Rajput, Neeraj Sharma. Development, Formulation and Evaluation of Sustain Release Dispersible Tablet of Ornidazole. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(3):174-8. doi: 10.52711/0975-4377.2021.00031 Available on: https://rjpdft.com/AbstractView.aspx?PID=2021-13-3-2
1. Siddiqui MN, Garg G, Sharma PK. Fast dissolving tablets: preparation, characterization and evaluation: an overview. International Journal of Pharmaceutical Sciences Review and Research. 2010 Sep;4(2):87-96.
2. Liberman HA and Lachman L. Pharmaceutical Dosage Forms: Tablets. Marcel Dekker Inc. New York. 2nd edition. I: 367-415 (2003).
3. Lindgren S, Janzon L. Dysphagia: Prevalence of swallowing complaints and clinical finding. Med Clin North Am. 1993;77: 3-5.
4. Bhise S, Chaulang G, Patel P, Bhosale A, Hardikar S. Superdisintegrants as solubilizing agent. Research Journal of Pharmacy and Technology. 2009; 2(2):387-91.
5. Kuchekar BS, Bhise SB, Arumugam V. Design of fast dissolving tablets. Indian journal of pharmaceutical education. 2001; 35(4):150-2.
6. Lachman L, Liberman HA and Kanig, JL. Capsules, The Theory and Practice of Industrial Pharmacy, 3rd Edn. Varghese Publishing House, 1991; 420-423.
7. Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid disintegrating tablets. AAPS pharmscitech. 2007 Jun 1;8(2): E127-33.
8. Shen RW, inventor; Upjohn Co, assignee. Taste masking of ibuprofen by fluid bed coating. United States patent US 5,552,152. 1996 Sep 3.
9. Kumar KM, Jena A, Ruckmani K, Rajendran P. Formulation and evaluation of taste masked orally disintegrating ondansetron hydrochloride tablet. Int. J. Res. Pharm. Sci. 2010;1(3):328-32.
10. Tripathi KD. Essencials of medical pharmacology, jaypee brother medical publisher pvt.ltd, 5th edition 2003
11. Rubino JT, Swarbrick J, Boylan J. Encyclopedia of pharmaceutical technology. Dekker, Inc. 1988;3: 375-98.
12. Agarwal R, Mittal R, Singh A. Studies of ion exchange resin complex of chloroquine phosphate. Drug development and industrial pharmacy. 2000 Jan 1;26(7):773-6.
13. Corbo M, Desai J, Patell M, Warrick R, inventors; Bristol-Myers Squibb Co, assignee. Taste masking coating composition. United States patent US 6,551,617. 2003 Apr 22.
14. Formulation development and evaluation of taste masking efficiency using the electronic tongue. Eur. J.Pharm. and biopharm. 66:460-465 (2007).
15. Hardikar S. Bhosale AV, Pathak AA, Sable RV Investigation of hydrogel isolated from seeds of Ocimum basilicum as binder. Indian J Pharm Science 2009:71(3):320-322.
16. Moneghini M, Bellich B, Baxa P, Princivalle F. Microwave generated solid dispersions containing ibuprofen. International journal of pharmaceutics. 2008 Sep 1;361(1-2):125-30.
17. Moneghini M, Zingone G, De Zordi N. Influence of the microwave technology on the physical–chemical properties of solid dispersion with Nimesulide. Powder technology. 2009 Nov 10;195(3):259-63.
18. Ishikawa T, Watanabe Y, Utoguchi N, Matsumoto M. Preparation and Evaluation of Tablets Rapidly Disintegrating in Salive Containing Bitter-Taste- Masked Granules by the Compression Method. Chemical and pharmaceutical bulletin. 1999 Oct 15; 47(10):1451-4.
19. Friend DR, Ng S, Sarabia RE, Weber TP, Geoffroy JM, inventors; Adare Pharmaceuticals Inc, assignee. Taste-masked microcapsule compositions and methods of manufacture. United States patent US 6,139,865. 2000 Oct 31.
20. Itoh A, Niwa T, inventors; Pfizer Inc, assignee. Rapidly releasing and taste-masking pharmaceutical dosage form. United States patent US 6,221,402. 2001 Apr 24.
21. Mahore JG, Wadher KJ, Milind JU. Formulation and in vitro evaluation of taste masked orodispersible tablet of metoclopramide hydrochloride. International Journal of Pharm Tech Research. 2010;2(3):1827-35.
22. Dobetti L. (Eurand International), Fast disintegrating tablets. 1999; PCT Patent WO 99/44580-A1;
23. Meneaud P, Al-ghazawi AKA and Elder DP. Water Dispersible Formulation of Paroxetine, Can. Pat. 2001; Appl. CA2399411
24. Nouri N, Zuccarelli JM, Chauveau C, Bruna E, inventors; Ethypharm, assignee. Process for manufacturing coated granules with masked taste and immediate release of the active principle. United States patent US 6,660,382. 2003 Dec 9.
25. Nagaraju N, Soni PK, Mukherji G, inventors; Jubilant Organosys Ltd, assignee. Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same. United States patent application US 12/528,859. 2010 Jan 21.
26. Pharmacopoeia of India, 4th ed. Vol. 2, New Delhi: Controller of Publication; 1996. p. A-99
27. Patel DM, Patel NM, Shah RR, Jogani PD, Balapatel AI. Studies in formulation of orodispersible tablets of rofecoxib. Indian journal of pharmaceutical sciences. 2004; 66 (5):621.
28. Lieberman HA, Lachman L and Schwartz JB. Pharmaceutical Dosage Forms: Tablets, 2nd Edn., 1989; Vol. 1, Marcel Dekker, Inc., 381.
29. Allen Jr LV, Wang B, inventors; University of Oklahoma, assignee. Particulate support matrix for making a rapidly dissolving tablet. United States patent US 5,595,761. 1997 Jan 21.
30. British pharmacopoeia 2005. The stationary office of the medicine and healthcare productsBrown D. Orally Disintegrating Tablets- Taste over Speed. Drug DeliveryTechnology. 2003; 3:58-61.
31. Gupta GD, Patel P. Fast Dissolving Drug Delivery Systems.“An update” pharmacy industry 2005‐2007.
32. Gao Y, Guan Y, Yang L, Wang YS, Zhang LN. Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking. International journal of pharmaceutics. 2006 Aug 2;318(1-2):62-9.
33. Martindale. The complete drug reference; 33rd Edn; Pharmaceutical Press; Edited by Sean C. Sweetman London. 1241-1242.
34. British Pharmacopoeia. 2004; vol-II; pp.1431-1432.
35. Lachman L, Liberman HA, and Kanig JL. Liquids, The Theory and Practice of Industrial Pharmacy, 3rd Edn.Varghese Publishing House. 1991; 468-470.
36. Lachman L, Liberman HA and Kanig JL. Sustained Release Dosage Form, The Theory and Practice of Industrial Pharmacy, 3rd Edn, Varghese Publishing House. 1991; 450.